OM · Categories · Form 4

OM - SEC Form 4 insider transactions

Outset Medical Inc. (OM) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for OM

• 16d
  Chair and CEO Trigg Leslie sold $12,746 worth of shares (3,445 units at $3.70), decreasing direct ownership by 3% to 98,874 units (SEC Form 4) to satisfy tax liability

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 16d
  EVP Operations R&D & Service Nash Marc sold $5,853 worth of shares (1,582 units at $3.70), decreasing direct ownership by 4% to 38,393 units (SEC Form 4) (tax withholding)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 16d
  General Counsel Brottem John L. sold $9,761 worth of shares (2,638 units at $3.70), decreasing direct ownership by 8% to 30,277 units (SEC Form 4) (for withholding tax)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 17d
  Large owner Leonard Braden Michael exercised 323,000 in-the-money shares at a strike of $5.00 (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 23d
  Large owner Leonard Braden Michael exercised 294,500 in-the-money shares at a strike of $5.00 (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 57d
  SEC Form 4 filed by Elliott Derick A.

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 105d
  General Counsel Brottem John L. sold $9,521 worth of shares (2,842 units at $3.35), decreasing direct ownership by 8% to 32,935 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 105d
  Chair and CEO Trigg Leslie sold $11,259 worth of shares (3,361 units at $3.35), decreasing direct ownership by 3% to 102,342 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 105d
  EVP Operations R&D & Service Nash Marc sold $6,087 worth of shares (1,817 units at $3.35), decreasing direct ownership by 4% to 39,988 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 134d
  EVP Operations R&D & Service Nash Marc sold $32,400 worth of shares (6,355 units at $5.10), decreasing direct ownership by 13% to 41,805 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 134d
  General Counsel Brottem John L. sold $53,599 worth of shares (10,494 units at $5.11), decreasing direct ownership by 23% to 35,777 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 134d
  Chair and CEO Trigg Leslie sold $71,091 worth of shares (13,914 units at $5.11), decreasing direct ownership by 12% to 105,703 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 143d
  Director Prange Karen was granted 18,667 shares (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 147d
  EVP Operations R&D & Service Nash Marc sold $461 worth of shares (108 units at $4.27), decreasing direct ownership by 0.22% to 48,160 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 147d
  General Counsel Brottem John L. sold $956 worth of shares (224 units at $4.27), decreasing direct ownership by 0.48% to 46,271 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 147d
  Chair and CEO Trigg Leslie sold $7,665 worth of shares (1,795 units at $4.27), decreasing direct ownership by 1% to 119,617 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 184d
  Director Drexler Karen sold $6,765 worth of shares (1,548 units at $4.37), decreasing direct ownership by 13% to 10,650 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 198d
  Chair and CEO Trigg Leslie sold $4,214 worth of shares (916 units at $4.60), decreasing direct ownership by 0.75% to 121,412 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 198d
  EVP Operations R&D & Service Nash Marc sold $1,136 worth of shares (247 units at $4.60), decreasing direct ownership by 0.51% to 48,268 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 198d
  General Counsel Brottem John L. sold $1,785 worth of shares (388 units at $4.60), decreasing direct ownership by 0.83% to 46,495 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 283d
  EVP, R&D, Operations and Serv. Nash Marc was granted 5,617 shares, increasing direct ownership by 13% to 48,515 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 290d
  Chair and CEO Trigg Leslie sold $11,644 worth of shares (904 units at $12.88), decreasing direct ownership by 0.73% to 122,328 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 290d
  SVP Operations and R&D Nash Marc sold $3,130 worth of shares (243 units at $12.88), decreasing direct ownership by 0.56% to 42,898 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 290d
  General Counsel Brottem John L. sold $4,933 worth of shares (383 units at $12.88), decreasing direct ownership by 0.81% to 46,883 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 358d
  SVP Operations and R&D Nash Marc was granted 29,676 shares, increasing direct ownership by 220% to 43,141 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 358d
  General Counsel Brottem John L. was granted 35,993 shares, increasing direct ownership by 319% to 47,266 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 358d
  Chair and CEO Trigg Leslie was granted 65,103 shares, increasing direct ownership by 112% to 123,232 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 358d
  Chief Financial Officer Gaeta Renee was granted 131,425 shares (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 365d
  Director Saia Andrea Lynn was granted 8,983 shares, increasing direct ownership by 281% to 12,175 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 365d
  Director Oboyle Kevin C was granted 8,983 shares, increasing direct ownership by 59% to 24,118 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 365d
  Director Lang Brent D. was granted 8,983 shares, increasing direct ownership by 101% to 17,851 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 365d
  Director Hackett Patrick T was granted 8,983 shares, increasing direct ownership by 10% to 95,172 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 365d
  Director Grossman D Keith was granted 8,983 shares, increasing direct ownership by 182% to 13,918 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 365d
  Director Drexler Karen was granted 8,983 shares, increasing direct ownership by 279% to 12,198 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 384d
  Chair and CEO Trigg Leslie sold $16,643 worth of shares (935 units at $17.80), decreasing direct ownership by 2% to 58,129 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 384d
  SVP Operations and R&D Nash Marc sold $4,491 worth of shares (252 units at $17.82), decreasing direct ownership by 2% to 13,465 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 384d
  General Counsel Brottem John L. sold $7,057 worth of shares (396 units at $17.82), decreasing direct ownership by 3% to 11,273 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 384d
  Chief Financial Officer Ahmed Nabeel sold $10,401 worth of shares (584 units at $17.81), decreasing direct ownership by 4% to 16,096 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 386d
  Director Oboyle Kevin C was granted 15,135 shares (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 450d
  Chair and CEO Trigg Leslie converted options into 625,000 shares (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 450d
  Director Lang Brent D. converted options into 250,000 shares (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 450d
  Director Drexler Karen converted options into 31,250 shares (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 450d
  Director Grossman D Keith converted options into 187,500 shares (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 450d
  Director Hackett Patrick T converted options into 3,125,000 shares, increasing direct ownership by 2,917% to 1,292,849 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 470d
  Chair and CEO Trigg Leslie sold $13,150 worth of shares (14,611 units at $0.90), decreasing direct ownership by 2% to 880,969 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 470d
  SVP Operations and R&D Nash Marc sold $3,784 worth of shares (4,204 units at $0.90), decreasing direct ownership by 2% to 200,764 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 470d
  General Counsel Brottem John L. sold $5,530 worth of shares (6,145 units at $0.90), decreasing direct ownership by 3% to 175,043 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 470d
  Chief Financial Officer Ahmed Nabeel sold $7,793 worth of shares (8,659 units at $0.90), decreasing direct ownership by 3% to 250,210 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 498d
  Chair and CEO Trigg Leslie was granted 99,419 shares and sold $52,189 worth of shares (65,236 units at $0.80), increasing direct ownership by 4% to 895,580 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 498d
  SVP Operations and R&D Nash Marc was granted 5,898 shares and sold $18,577 worth of shares (23,221 units at $0.80), decreasing direct ownership by 8% to 204,968 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 498d
  General Counsel Brottem John L. was granted 9,090 shares and sold $26,344 worth of shares (32,930 units at $0.80), decreasing direct ownership by 12% to 181,188 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 498d
  Chief Financial Officer Ahmed Nabeel was granted 13,256 shares and sold $27,430 worth of shares (34,288 units at $0.80), decreasing direct ownership by 8% to 258,869 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 507d
  Chair and CEO Trigg Leslie sold $26,914 worth of shares (33,227 units at $0.81), decreasing direct ownership by 4% to 861,397 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 507d
  SVP Operations and R&D Nash Marc sold $12,159 worth of shares (15,011 units at $0.81), decreasing direct ownership by 6% to 222,291 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 507d
  General Counsel Brottem John L. sold $16,599 worth of shares (20,492 units at $0.81), decreasing direct ownership by 9% to 205,028 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 507d
  Chief Financial Officer Ahmed Nabeel sold $23,515 worth of shares (29,031 units at $0.81), decreasing direct ownership by 9% to 279,901 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 513d
  Chair and CEO Trigg Leslie sold $13,193 worth of shares (10,227 units at $1.29), decreasing direct ownership by 1% to 894,624 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 513d
  SVP Operations and R&D Nash Marc sold $929 worth of shares (720 units at $1.29), decreasing direct ownership by 0.30% to 237,302 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 513d
  General Counsel Brottem John L. sold $2,028 worth of shares (1,572 units at $1.29), decreasing direct ownership by 0.69% to 225,520 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)
• 513d
  Chief Financial Officer Ahmed Nabeel sold $2,367 worth of shares (1,835 units at $1.29), decreasing direct ownership by 0.59% to 308,932 units (SEC Form 4)

  4 - Outset Medical, Inc. (0001484612) (Issuer)

Other OM categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends